A groundbreaking study has shed light on the complex interactions between dystrophin, a protein critical to muscle stability, and its partner protein, dystrobrevin, offering new pathways for understanding and treating Duchenne Muscular Dystrophy (DMD).
Categories
Recent Posts
- Your Guide to Genetic Testing for Neuromuscular Diseases
- Finding balance while parenting children with DMD can be tricky
- Finding harmony and inclusion in life through music
- CureDuchenne’s latest investment aims to address the limitations of current AAV-delivered gene therapy treatments for Duchenne muscular dystrophy (DMD).
- Elevidys halted in nonambulatory DMD after second death reported